Back to search

University of British Columbia

LINE-1 retrotranspositions in epithelial ovarian cancer : can we use DNA “parasites” for good purpose?

Abstract

dc:description

High grade serous ovarian cancer (HGSC), endometrioid ovarian cancer (ENOC) and clear cell ovarian cancer (CCOC) are the three most common subtypes of epithelial ovarian cancers (EOC). While HGSC arise from serous tubal intraepithelial carcinomas (STIC) lesions in the fallopian tube, ENOC and CCOC share a common precursor lesion, endometriosis (ectopic growth of uterine lining). Effective biomarkers of early cancer development and recurrence are lacking. We performed whole genome sequencing (WGS) and observed highly recurrent retrotransposition events originating from an active LINE-1 retrotransposon (L1) in the TTC28 gene in one-third of our ENCO and CCOC cohort. L1s are mobile genetic elements that encodes their own protein machineries to “copy-and-paste” their sequences into random genomic loci. A process called 3’ transduction occur when L1s insert the unique downstream DNA sequences along with their own sequences. All these processes may fuel genomic instability, as such L1s are epigenetically silenced in normal tissues, but are found to be re-activated in cancers and cancer precursor lesions. We hypothesize that L1s activate early in EOC tumorigenesis and that TTC28-L1 3’ transductions could be used as markers of tumor development and progression. Using conventional and multiplex PCR on formalin-fixed paraffin-embedded (FFPE) tumor tissues, we found that TTC28-L1 3’ transductions occurred early and preceded many somatic mutations. We developed a probe-based target capture sequencing method that could identify novel TTC28-L1 3’ transductions in frozen tumor and FFPE tissues, and potentially in circulating tumor DNA. Using immunohistochemistry (IHC), we observed high L1 protein expressions in HGSC and its precursor lesions. Our results suggest that TTC28-L1 events occur early in EOC development and L1 protein expressions may reflect pre-malignant transformations. The use of L1 protein IHC and our target capture assay could be explored as a potential method to track such development.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Pathology and Laboratory Medicine
Grantor dc:publisher
University of British Columbia
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Xia, Zhouchunyang

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/67443

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Xia, Zhouchunyang. LINE-1 retrotranspositions in epithelial ovarian cancer : can we use DNA “parasites” for good purpose?. master's thesis, University of British Columbia, 2018. http://hdl.handle.net/2429/67443